[Genetic disorders in primary brain glioblastomas]

Vopr Onkol. 2016;62(4):471-8.
[Article in Russian]

Abstract

Glioblastomas are characterized by a variety of genetic and epigenetic disorders, identification of which allows constantly expanding a list of genes directly involved in carcinogenesis, thus increasing molecular diagnostics, monitoring and predicting disease. Molecular-genetic studies of patients with glioblastomas allowed revealing changes relevant to this disease and determining their prognostic significance. In the future molecular-biological markers along with clinical and therapeutic factors may play a role of separate and independent factors of prognosis in patients with malignant brain lesions.

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Carcinogenesis / genetics*
  • DNA Modification Methylases / genetics
  • DNA Mutational Analysis
  • DNA Repair Enzymes / genetics
  • Disease-Free Survival
  • ErbB Receptors / genetics
  • Female
  • Glioblastoma / epidemiology
  • Glioblastoma / genetics*
  • Glioblastoma / pathology
  • Humans
  • Isocitrate Dehydrogenase / genetics
  • Male
  • Middle Aged
  • Peroxiredoxins / genetics
  • Prognosis*
  • Promoter Regions, Genetic
  • Tumor Suppressor Proteins / genetics

Substances

  • Biomarkers, Tumor
  • Tumor Suppressor Proteins
  • IDH2 protein, human
  • Isocitrate Dehydrogenase
  • IDH1 protein, human
  • PRDX1 protein, human
  • Peroxiredoxins
  • DNA Modification Methylases
  • MGMT protein, human
  • EGFR protein, human
  • ErbB Receptors
  • DNA Repair Enzymes